Hypoglycemic Agents: all 3,927 studies that test it

Page 14 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)CompletedNCT00482729Phase 3Results posted
• Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And AdolescentsTerminatedNCT00479258Phase 3Results posted
• Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 DiabetesCompletedNCT00474045Phase 3Results posted
• Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)CompletedNCT00473876Phase 4Results posted
• Effects of PPAR Ligands on Ectopic Fat Accumulation and InflammationCompletedNCT00470262Not applicableResults posted
• Insulin Secretion in Diabetes Before and After Glycemic ControlCompletedNCT00469833Not applicableResults posted
• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesCompletedNCT00469092Phase 4Results posted
• A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesCompletedNCT00467649Phase 4Results posted
• Comparison of Insulins Aspart and Lispro in Insulin PumpsCompletedNCT00461331Phase 4Results posted
• Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCompletedNCT00455858Phase 4Results posted
• Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)CompletedNCT00449930Phase 3Results posted
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedNCT00447382Phase 3Results posted
• Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin ResistanceCompletedNCT00443755Phase 2Results posted
• SPECS: Safe Pediatric Euglycemia in Cardiac SurgeryCompletedNCT00443599Not applicableResults posted
• Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes MellitusCompletedNCT00442767Phase 4Results posted
• Pioglitazone to Treat Fatty Liver in People With HIV InfectionCompletedNCT00441272Phase 2Results posted
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT00435019Phase 3Results posted
• A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo StudyCompletedNCT00432679Phase 3Results posted
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00432276Phase 3Results posted
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump TherapyTerminatedNCT00428207Not applicableResults posted
• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00428090Phase 3Results posted
• Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate CancerCompletedNCT00427999Phase 2Results posted
• Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial TriglycerideCompletedNCT00424762Phase 4Results posted
• A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine DependenceCompletedNCT00421603Phase 2Results posted
• Beta-Cell Function and Sitagliptin Trial (BEST)CompletedNCT00420511Phase 2Results posted
• A Study for Patients With Diabetes Mellitus (IOPA)CompletedNCT00420095Phase 4Results posted
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes MellitusCompletedNCT00419562Phase 3Results posted
• This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes MellitusCompletedNCT00418522Phase 4Results posted
• Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in YouthCompletedNCT00413335Not applicableResults posted
• A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)CompletedNCT00411554Phase 3Results posted
• Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 DiabetesCompletedNCT00411411Phase 3Results posted
• Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapineCompletedNCT00401973Phase 3Results posted
• Lifestyle Modification and Metformin Use in the Treatment of HIVCompletedNCT00399360Not applicableResults posted
• Initial Combination With Pioglitazone Study (0431-064)CompletedNCT00397631Phase 3Results posted
• Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedNCT00395512Phase 3Results posted
• Sitagliptin Added-on to Insulin Study (0431-051)CompletedNCT00395343Phase 3Results posted
• Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With OlanzapineCompletedNCT00394095Phase 4Results posted
• Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar ManiaCompletedNCT00393978Phase 4Results posted
• Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)CompletedNCT00393705Phase 4Results posted
• A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese SubjectsCompletedNCT00392925Phase 2Results posted
• A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®CompletedNCT00391027Phase 4Results posted
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes MellitusCompletedNCT00385697Phase 2/3Results posted
• Insulin Glargine "All to Target" TrialCompletedNCT00384085Phase 4Results posted
• Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00381238Phase 2Results posted
• RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesCompletedNCT00379769Phase 3Results posted
• Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)CompletedNCT00377858Phase 4Results posted
• MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)CompletedNCT00372060Phase 3Results posted
• Rosiglitazone Effect on Mitochondria and LipoatrophyCompletedNCT00367744Phase 2Results posted
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 DiabetesCompletedNCT00367055Phase 4Results posted
• The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 DiabetesTerminatedNCT00366301Phase 4Results posted
• Incretins in Impaired Fasting GlucoseCompletedNCT00364377Phase 4Results posted
• Insulin Glulisine in Type 2 Diabetic PatientsCompletedNCT00360698Phase 4Results posted
• Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With HyperglycaemiaCompletedNCT00353431Not applicableResults posted
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedNCT00350779Phase 3Results posted
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00348309Not applicableResults posted
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00348140Phase 3Results posted
• Topiramate for the Treatment of Methamphetamine Dependence - 1CompletedNCT00345371Phase 2Results posted
• Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus InsulinCompletedNCT00338104Phase 4Results posted
• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00337610Phase 3Results posted
• Rosiglitazone for Clozapine Induced Glucose Metabolism ImpairmentCompletedNCT00337350Phase 4Results posted
• The Effects of Topiramate on Alcohol Use in Alcohol Dependent SubjectsCompletedNCT00329407Phase 4Results posted
• Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00328627Phase 3Results posted
• Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsCompletedNCT00328172Phase 2Results posted
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00327015Phase 3Results posted
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic NephropathyCompletedNCT00324675Not applicableResults posted
• Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00322868Not applicableResults posted
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 DiabetesCompletedNCT00318656Phase 4Results posted
• Optimizing Body Composition for Function in Older AdultsCompletedNCT00315146Phase 4Results posted
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 DiabetesCompletedNCT00309608Phase 2Results posted
• Perioperative Insulin Glargine Dosing StudyCompletedNCT00309465Phase 4Results posted
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-upCompletedNCT00309244Phase 3Results posted
• Safety of Inhaled Insulin With Type 1 and Type 2 DiabetesCompletedNCT00308737Phase 3Results posted
• Long-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusCompletedNCT00306384Phase 3Results posted
• Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)CompletedNCT00305604Phase 3Results posted
• Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered IndividualsCompletedNCT00300742Phase 2Results posted
• Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDLCompletedNCT00300365Phase 2Results posted
• MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)CompletedNCT00289848Phase 3Results posted
• Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted
• Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedNCT00286468Phase 3Results posted
• Efficacy and Safety of Alogliptin in Subjects With Type 2 DiabetesCompletedNCT00286455Phase 3Results posted
• Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes MellitusCompletedNCT00286442Phase 3Results posted
• Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.CompletedNCT00286429Phase 3Results posted
• Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive TherapyCompletedNCT00283816Phase 3Results posted
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlTerminatedNCT00283049Phase 4Results posted
• A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes MellitusTerminatedNCT00282971Phase 3Results posted
• Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's DiseaseCompletedNCT00265148Phase 2Results posted
• The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET StudyCompletedNCT00264641Not applicableResults posted
• Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT00252499Not applicableResults posted
• Topiramate in the Treatment of Pathological GamblingTerminatedNCT00245583Phase 3Results posted
• Insulin Resistance in Patients With Mood DisorderCompletedNCT00242619Not applicableResults posted
• PsA Treatment With hOKT3γ1 (Ala-Ala)TerminatedNCT00239720Phase 2Results posted
• Preservation of Beta-cell Function in Type 2 Diabetes MellitusCompletedNCT00232583Not applicableResults posted
• Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With SchizophreniaCompletedNCT00231894Phase 4Results posted
• Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes MellitusCompletedNCT00225277Phase 3Results posted
• Actos Now for Prevention of Diabetes (ACT NOW)CompletedNCT00220961Phase 3Results posted
• An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.CompletedNCT00206336Phase 3Results posted
• A Randomized, Placebo-controlled, Tourette Syndrome Study.CompletedNCT00206323Phase 3Results posted
• Polycystic Ovary Syndrome (PCOS) and Sleep ApneaTerminatedNCT00203996Phase 4Results posted
• Preferred Treatment of Type 1.5 DiabetesCompletedNCT00194896Not applicableResults posted
• Hyperglycemia and Cardiovascular Outcomes With Type 2 DiabetesCompletedNCT00191282Phase 4Results posted

← Hypoglycemic Agents overview